Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. No observable changes to study content or user-facing information in the screenshot.SummaryDifference0.0%

- Check21 days agoChange DetectedPubMed publications note updated to indicate that items are automatically filled from PubMed and may not all be about the study. Revision: v3.3.1 was added to the page.SummaryDifference0.1%

- Check28 days agoChange DetectedThe 'Notice Because of a lapse in government funding...' warning has been removed from the page. It previously stated that information might not be up to date and inquiries could be delayed.SummaryDifference0.2%

- Check43 days agoChange DetectedThe Study Details page remains the same, with identical sections and values across screenshots; only minor formatting/layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedUpdate: the page version is updated from v3.0.2 to v3.2.0. No other content changes detected.SummaryDifference0.0%

- Check74 days agoChange DetectedUpdated the revision/version from v3.0.2 to v3.1.0, indicating a new release with presumably updated features or fixes, while core content remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.